| Ticker Details |
|
Sana Biotechnology, Inc.
|
| IPO Date: |
February 1, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$854.36M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.33 | 4.27%
|
| Avg Daily Range (30 D): |
$0.11 | 3.13%
|
| Avg Daily Range (90 D): |
$0.12 | 3.37%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.99M |
| Avg Daily Volume (30 D): |
3.77M |
| Avg Daily Volume (90 D): |
2.74M |
| Trade Size |
| Avg Trade Size (Sh.): |
148 |
| Avg Trade Size (Sh.) (30 D): |
224 |
| Avg Trade Size (Sh.) (90 D): |
173 |
| Institutional Trades |
| Total Institutional Trades: |
1,533 |
| Avg Institutional Trade: |
$1.82M |
| Avg Institutional Trade (30 D): |
$2.59M |
| Avg Institutional Trade (90 D): |
$1.7M |
| Avg Institutional Trade Volume: |
.27M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.89M |
| Avg Closing Trade (30 D): |
$.96M |
| Avg Closing Trade (90 D): |
$1.06M |
| Avg Closing Volume: |
273.28K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.93
|
$-.17
|
$-.21
|
|
Diluted EPS
|
$-.93
|
$-.17
|
$-.21
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-241.99M
|
$-47.21M
|
$-58.83M
|
|
Operating Income / Loss
|
$-248.3M
|
$-48.61M
|
$-61.2M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-12.33M
|
$11.93M
|
$-31.49M
|
|
PE Ratio
|
|
|
|
|
|
|